| (S)-nicotine | increases expression | ISO | RGD:731575 | 6480464 | Nicotine results in increased expression of CALR mRNA | CTD | PMID:16949557 |
| 1,3-dinitrobenzene | increases metabolic processing | EXP | | 6480464 | 3-dinitrobenzene results in increased metabolism of CALR protein | CTD | PMID:21402099 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1550061 | 6480464 | Ethinyl Estradiol affects the expression of CALR mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1550061 | 6480464 | Ethinyl Estradiol results in increased expression of CALR mRNA | CTD | PMID:16174780 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CALR mRNA | CTD | PMID:16174780 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CALR mRNA | CTD | PMID:17108234 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1550061 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALR mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1550061 | 6480464 | Ethinyl Estradiol results in increased expression of CALR mRNA | CTD | PMID:17942748 PMID:16174780 |
| 2,2,2-tetramine | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of CALR protein] | CTD | PMID:19634143 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550061 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALR mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CALR protein | CTD | PMID:19201780 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550061 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CALR mRNA | CTD | PMID:17942748 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | ISO | RGD:731575 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of CALR mRNA | CTD | PMID:17547211 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CALR mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:1550061 | 6480464 | Glucosamine results in decreased expression of CALR mRNA | CTD | PMID:17178593 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1550061 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CALR mRNA | CTD | PMID:18648102 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:731575 | 6480464 | Fenretinide results in increased expression of CALR protein | CTD | PMID:17353921 |
| 4-methylumbelliferyl acetate | increases activity | ISO | RGD:731575 | 6480464 | 4-methylumbelliferyl acetate results in increased activity of CALR protein | CTD | PMID:20188080 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:1550061 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CALR mRNA | CTD | PMID:21785161 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:731575 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CALR mRNA | CTD | PMID:22079614 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:1550061 | 6480464 | Glucosamine results in decreased expression of CALR mRNA | CTD | PMID:17178593 |
| ammonium chloride | decreases expression | EXP | | 6480464 | Ammonium Chloride results in decreased expression of CALR protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CALR mRNA | CTD | PMID:16483693 |
| ampicillin | increases expression | ISO | RGD:731575 | 6480464 | Ampicillin results in increased expression of CALR mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550061 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CALR mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | affects expression | ISO | RGD:1550061 | 6480464 | Benzo(a)pyrene affects the expression of CALR mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1550061 | 6480464 | Benzo(a)pyrene results in decreased expression of CALR mRNA | CTD | PMID:20504355 |
| beta-D-glucosamine | decreases expression | ISO | RGD:1550061 | 6480464 | Glucosamine results in decreased expression of CALR mRNA | CTD | PMID:17178593 |
| bucladesine | increases stability | ISO | RGD:1550061 | 6480464 | Bucladesine results in increased stability of CALR protein | CTD | PMID:9473613 |
| cadmium atom | increases expression | ISO | RGD:731575 | 6480464 | Cadmium results in increased expression of CALR mRNA | CTD | PMID:21694771 |
| calcium atom | affects response to substance | ISO | RGD:1550061 | 6480464 | CALR protein affects the susceptibility to Calcium | CTD | PMID:7961812 |
| calcium atom | multiple interactions | ISO | RGD:1550061 | 6480464 | CALR protein promotes the reaction [KNG1 protein modified form results in increased abundance of Calcium] | CTD | PMID:7961812 |
| calcium(0) | affects response to substance | ISO | RGD:1550061 | 6480464 | CALR protein affects the susceptibility to Calcium | CTD | PMID:7961812 |
| calcium(0) | multiple interactions | ISO | RGD:1550061 | 6480464 | CALR protein promotes the reaction [KNG1 protein modified form results in increased abundance of Calcium] | CTD | PMID:7961812 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of CALR mRNA | CTD | PMID:18172885 |
| chlorpromazine | decreases expression | EXP | | 6480464 | Chlorpromazine results in decreased expression of CALR mRNA | CTD | PMID:18246545 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of CALR mRNA | CTD | PMID:20691718 |
| choline | multiple interactions | ISO | RGD:1550061 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CALR mRNA | CTD | PMID:20938992 |
| chromium atom | decreases expression | ISO | RGD:731575 | 6480464 | Chromium results in decreased expression of CALR mRNA | CTD | PMID:17547211 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CALR mRNA | CTD | PMID:18246545 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CALR mRNA | CTD | PMID:21318169 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALR mRNA | CTD | PMID:17602206 |
| cobalt dichloride | decreases expression | ISO | RGD:731575 | 6480464 | cobaltous chloride results in decreased expression of CALR mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | decreases expression | ISO | RGD:731575 | 6480464 | cobaltous chloride results in decreased expression of CALR mRNA | CTD | PMID:19320972 PMID:19376846 |
| cocaine | decreases expression | ISO | RGD:1550061 | 6480464 | Cocaine results in decreased expression of CALR mRNA | CTD | PMID:18355967 |
| cocaine | multiple interactions | ISO | RGD:1550061 | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of CALR mRNA] | CTD | PMID:18355967 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CALR mRNA | CTD | PMID:20187946 |
| copper atom | affects binding | ISO | RGD:731575 | 6480464 | CALR protein binds to Copper | CTD | PMID:15359738 |
| copper(0) | affects binding | ISO | RGD:731575 | 6480464 | CALR protein binds to Copper | CTD | PMID:15359738 |
| copper(2+) sulfate | decreases expression | ISO | RGD:731575 | 6480464 | Copper Sulfate results in decreased expression of CALR mRNA | CTD | PMID:19549813 |
| cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of CALR mRNA | CTD | PMID:18246545 PMID:11906922 |
| cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of CALR mRNA | CTD | PMID:11906922 PMID:18246545 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of CALR mRNA | CTD | PMID:11599041 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CALR mRNA | CTD | PMID:18172885 |
| cyclosporin A | increases expression | ISO | RGD:731575 | 6480464 | Cyclosporine results in increased expression of CALR mRNA | CTD | PMID:22147139 |
| D-glucose | decreases expression | ISO | RGD:1550061 | 6480464 | Glucose results in decreased expression of CALR mRNA | CTD | PMID:17178593 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of CALR mRNA | CTD | PMID:11015613 |
| diarsenic trioxide | decreases expression | ISO | RGD:731575 | 6480464 | arsenic trioxide results in decreased expression of CALR mRNA | CTD | PMID:20458559 |
| diazinon | increases expression | ISO | RGD:731575 | 6480464 | Diazinon results in increased expression of CALR mRNA | CTD | PMID:16758764 |
| diazoxide | increases expression | ISO | RGD:1550061 | 6480464 | Isoproterenol results in increased expression of CALR mRNA | CTD | PMID:21823215 |
| dibutyl phthalate | decreases expression | ISO | RGD:1550061 | 6480464 | Dibutyl Phthalate results in decreased expression of CALR mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1550061 | 6480464 | Dibutyl Phthalate results in decreased expression of CALR mRNA | CTD | PMID:17361019 PMID:21266533 |
| diclofenac | affects expression | EXP | | 6480464 | Diclofenac affects the expression of CALR mRNA | CTD | PMID:18246545 |
| diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of CALR mRNA | CTD | PMID:18246545 |
| doxorubicin | affects localization | ISO | RGD:1550061 | 6480464 | Doxorubicin affects the localization of CALR protein | CTD | PMID:17187072 |
| elemental selenium | multiple interactions | ISO | RGD:731575 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA | CTD | PMID:19244175 |
| elemental selenium | decreases expression | ISO | RGD:731575 | 6480464 | Selenium results in decreased expression of CALR mRNA | CTD | PMID:19244175 |
| ellagic acid | decreases expression | ISO | RGD:731575 | 6480464 | Ellagic Acid results in decreased expression of CALR mRNA | CTD | PMID:12002526 |
| flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CALR mRNA | CTD | PMID:15885261 |
| folic acid | multiple interactions | ISO | RGD:1550061 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CALR mRNA | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | decreases expression | EXP | | 6480464 | Lindane results in decreased expression of CALR mRNA | CTD | PMID:17785943 |
| glucose | decreases expression | ISO | RGD:1550061 | 6480464 | Glucose results in decreased expression of CALR mRNA | CTD | PMID:17178593 |
| halothane | affects metabolic processing | EXP | | 6480464 | Halothane metabolite affects the metabolism of CALR | CTD | PMID:1504264 |
| hyaluronic acid | decreases expression | EXP | | 6480464 | Hyaluronic Acid analog results in decreased expression of CALR protein | CTD | PMID:23178681 |
| hydrogen peroxide | affects expression | ISO | RGD:731575 | 6480464 | Hydrogen Peroxide affects the expression of CALR protein | CTD | PMID:21179406 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CALR protein | CTD | PMID:23178681 |
| ionomycin | decreases response to substance | ISO | RGD:1550061 | 6480464 | CALR protein results in decreased susceptibility to Ionomycin | CTD | PMID:7961812 |
| iron atom | increases expression | ISO | RGD:731575 | 6480464 | Iron results in increased expression of CALR protein; more ... | CTD | PMID:11500943 |
| isoprenaline | increases expression | ISO | RGD:1550061 | 6480464 | Isoproterenol results in increased expression of CALR mRNA | CTD | PMID:21823215 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:1550061 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CALR mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:1550061 | 6480464 | lead acetate results in decreased expression of CALR mRNA | CTD | PMID:21829687 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of CALR mRNA; more ... | CTD | PMID:16236328 |
| lithocholic acid | affects expression | EXP | | 6480464 | Lithocholic Acid affects the expression of CALR mRNA | CTD | PMID:18246545 |
| lovastatin | increases expression | ISO | RGD:1550061 | 6480464 | Lovastatin results in increased expression of CALR mRNA | CTD | PMID:20493250 |
| methotrexate | affects response to substance | ISO | RGD:731575 | 6480464 | CALR protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 |
| mitoxantrone | affects localization | ISO | RGD:1550061 | 6480464 | Mitoxantrone affects the localization of CALR protein | CTD | PMID:20003823 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALR mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA | CTD | PMID:18544905 |
| paracetamol | affects expression | ISO | RGD:1550061 | 6480464 | Acetaminophen affects the expression of CALR mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CALR mRNA | CTD | PMID:18246545 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CALR mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CALR mRNA | CTD | PMID:19162173 PMID:21318169 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1550061 | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in decreased expression of CALR mRNA] | CTD | PMID:21318169 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CALR mRNA | CTD | PMID:21318169 PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1550061 | 6480464 | perfluorooctanoic acid results in decreased expression of CALR mRNA | CTD | PMID:21318169 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CALR mRNA | CTD | PMID:16510358 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CALR mRNA | CTD | PMID:19162173 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:731575 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CALR mRNA | CTD | PMID:19031421 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CALR mRNA | CTD | PMID:16940010 |
| pirinixic acid | multiple interactions | ISO | RGD:1550061 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of CALR mRNA] | CTD | PMID:21318169 |
| pirinixic acid | decreases expression | ISO | RGD:1550061 | 6480464 | pirinixic acid results in decreased expression of CALR mRNA | CTD | PMID:21318169 |
| potassium dichromate | decreases expression | ISO | RGD:731575 | 6480464 | Potassium Dichromate results in decreased expression of CALR mRNA | CTD | PMID:17547211 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of CALR mRNA | CTD | PMID:16376865 |
| resveratrol | decreases expression | ISO | RGD:731575 | 6480464 | resveratrol results in decreased expression of CALR mRNA | CTD | PMID:12002526 |
| selenium atom | multiple interactions | ISO | RGD:731575 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA | CTD | PMID:19244175 |
| selenium atom | decreases expression | ISO | RGD:731575 | 6480464 | Selenium results in decreased expression of CALR mRNA | CTD | PMID:19244175 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of CALR protein | CTD | PMID:19634143 |
| streptozocin | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of CALR protein] | CTD | PMID:19634143 |
| tamoxifen | decreases expression | ISO | RGD:731575 | 6480464 | Tamoxifen results in decreased expression of CALR mRNA | CTD | PMID:16202921 |
| tamoxifen | affects expression | ISO | RGD:1550061 | 6480464 | Tamoxifen affects the expression of CALR mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:731575 | 6480464 | tert-Butylhydroperoxide results in decreased expression of CALR mRNA | CTD | PMID:15336504 |
| testosterone | affects expression | ISO | RGD:1550061 | 6480464 | Testosterone affects the expression of CALR mRNA | CTD | PMID:17003280 |
| testosterone | increases expression | ISO | RGD:731575 | 6480464 | Testosterone results in increased expression of CALR mRNA | CTD | PMID:20564326 |
| testosterone | multiple interactions | ISO | RGD:731575 | 6480464 | dutasteride promotes the reaction [Testosterone results in increased expression of CALR mRNA] | CTD | PMID:20564326 |
| thapsigargin | increases expression | ISO | RGD:731575 | 6480464 | Thapsigargin results in increased expression of CALR protein | CTD | PMID:17353921 |
| titanium dioxide | increases phosphorylation | ISO | RGD:731575 | 6480464 | titanium dioxide results in increased phosphorylation of CALR protein | CTD | PMID:21439344 |
| trans-resveratrol | decreases expression | ISO | RGD:731575 | 6480464 | resveratrol results in decreased expression of CALR mRNA | CTD | PMID:12002526 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CALR mRNA | CTD | PMID:19448997 |
| tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of CALR protein | CTD | PMID:15049342 |
| tunicamycin | increases expression | ISO | RGD:1550061 | 6480464 | Tunicamycin results in increased expression of CALR mRNA | CTD | PMID:22001960 |
| valproic acid | increases expression | ISO | RGD:1550061 | 6480464 | Valproic Acid results in increased expression of CALR mRNA | CTD | PMID:21427059 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CALR protein | CTD | PMID:16236328 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of CALR mRNA | CTD | PMID:18172885 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of CALR mRNA | CTD | PMID:18172885 |